Cargando…
Opioid Antagonists for Pharmacological Treatment of Gambling Disorder: Are they Relevant?
BACKGROUND: To date, no drugs have been approved for gambling disorder. Numerous publications have described the value of opioid antagonists. Indeed, the mesocorticolimbic dopaminergic pathway has been suggested as the underlying cause of reward-seeking behaviour, and it is modulated by the opioid s...
Autores principales: | Victorri-Vigneau, Caroline, Spiers, Andrew, Caillet, Pascal, Bruneau, Mélanie, Challet-Bouju, Gaëlle, Grall-Bronnec, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295935/ https://www.ncbi.nlm.nih.gov/pubmed/28721822 http://dx.doi.org/10.2174/1570159X15666170718144058 |
Ejemplares similares
-
Cognitive Remediation Interventions for Gambling Disorder: A Systematic Review
por: Challet-Bouju, Gaëlle, et al.
Publicado: (2017) -
Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review
por: Grall-Bronnec, Marie, et al.
Publicado: (2016) -
Prevalence of Coaddictions and Rate of Successful Treatment Among a French Sample of Opioid-Dependent Patients With Long-Term Opioid Substitution Therapy: The OPAL Study
por: Grall-Bronnec, Marie, et al.
Publicado: (2019) -
What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report
por: Guillou-Landreat, Morgane, et al.
Publicado: (2021) -
Dopamine Agonists and Impulse Control Disorders: A Complex Association
por: Grall-Bronnec, Marie, et al.
Publicado: (2017)